This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| BP PLC | 494.1 | 2.8% |
| BRITISH AMERICAN TOBACCO PLC | 3,352.0 | 2.7% |
| IMPERIAL BRANDS PLC | 1,922.2 | 2.5% |
| ROYAL DUTCH SHELL PLC-B SHS | 2,306.5 | 2.1% |
| ROYAL DUTCH SHELL PLC-A SHS | 2,298.5 | 1.9% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| EASYJET PLC | 1382.0 | -3.4% |
| ROYAL BANK OF SCOTLAND GROUP | 238.3 | -2.5% |
| JD SPORTS FASHION PLC | 811.2 | -2.4% |
| ANTOFAGASTA PLC | 922.8 | -2.4% |
| HALMA PLC | 2112.0 | -1.9% |
| Major World Indices | Price | % Chg | 1 Year |
| UK 100 INDEX | 7,622 | 0.2% | 11.5% |
| DOW JONES INDUS. AVG | 28,635 | -0.8% | 22.2% |
| DAX INDEX | 13,219 | -1.3% | 22.8% |
| NIKKEI 225 | 23,205 | -1.9% | 15.9% |
| S&P/ASX 200 INDEX | 6,736 | 0.0% | 19.9% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 64.11 | 1.68% |
| Brent Crude (ICE) | USD/bbl. | 69.89 | 1.88% |
| Gold Spot | USD/t oz. | 1,572 | 1.3% |
| Copper (Comex) | USd/lb. | 278 | -0.4% |
Click graph to enlarge
UK 100 called to open -40 points at 7585; This comes as Donald Trump warned Iran of "disproportionate" U.S. retaliation for any military action and threatened heavy sanctions on Iraq if American troops are expelled. This after Tehran declared it won't abide by any limits on uranium enrichment and Iraq's parliament voted to oust U.S. forces. Global tensions caused U.S markets to close the week in the red, the Dow Jones closed the week at 28,634 (-233 points), the S&P closed at 3,234 (-23 points), the Nasdaq closed at 9,020 (-71 points). It was a similar story overnight in Asia as sentiment continued to be weighed on, The Nikkei closed at 23,204 (-451 points), the Hang Seng closed at 28,169 (-282 points). The big winners overnight were crude oil, now trading at $71 per barrel at time of writing (15% up MoM) and traditional safe haven gold, trading at $1571 (7% higher than this time last month)
AstraZeneca’s drug Farxiga has been granted FDA Priority Review for patients with heart failure with reduced ejection fraction.
AstraZeneca also announce their drug Lokelma has been approved in China for the treatment of adult patients with hyperkalaemia (elevated levels of potassium in the blood).
Compass Group announce that Chairman and Director of the company Paul Walsh will step down to focus on other business interests and will not seek re-election at the 2021 AGM.
Dechra Pharmaceuticals announce that it has agreed terms to acquire the worldwide rights to the Osurnia product portfolio (Osurnia) from Elanco Animal Health Incorporated (Elanco) for a total consideration of £102.4 million.
NMC Health confirms the members of the Independent Review Oversight Committee. The results from the committee’s findings will be published well in advance of the company’s 2019 FY results.
Plus 500 year end trading update, expects to report revenue and EBITDA for the year of approximately $354 million and $190 million, respectively. The Board is pleased with this performance, reflecting a much improved second half compared to the first half.
Prudential Vietnam and SeABank establish exclusive bancassurance partnership with a 20-year term, effective from April 2020.
Wizz Air grows passenger numbers for December 2019 by 25% to 3.3m. Load factor increases by 0.6ppts to 89.4%.
Source: Bloomberg, FT, Reuters, DJ Newswires, AlphaTerminal
None
Hikma Downgraded to Underweight by JP Morgan (Bloomberg: 8 Buys/ 3 Holds/ 3 Sells)
Next Downgraded to Sell by Societe Generale (Bloomberg: 6 Buys/ 11 Holds/ 5 Sells)
Page Group Downgraded to Hold by Jefferies (Bloomberg: 6 Buys/ 8 Holds/ 0 Sells)
UK Markit services PMI
German Markit services PMI
Eurozone Markit services PMI
Chinese Caixin Services PMI
UK 100 :
Aveva
:
Brewin Dolphin Holdings
Paragon Banking Group
WH Smith
UDG Healthcare
Workspace Group
AJ Bell
QinetiQ Group
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.